Tags

Type your tag names separated by a space and hit enter

New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa.
J Small Anim Pract. 1997 Feb; 38(2):51-6.JS

Abstract

In order to compound a new drug combination against canine otitis externa (OE), 515 dogs affected with OE were subjected to physical examination and microbiological analysis of their ear exudates. OE was erythematous-ceruminous in 83 per cent and suppurative in 17 per cent of the patient material. Erythematous-ceruminous inflammations were characterised by severe pruritus and accumulation of brownish, greasy cerumen in the auditory canal. The yeast Malassezia pachydermatis was isolated from the ears of 76 per cent of the dogs, often in combination with Staphylococcus intermedius bacteria. M pachydermatis showed the most sensitivity, in decreasing order of efficacy, to ketoconazole, econazole, clotrimazole, miconazole and nystatin. S intermedius isolates were most sensitive to amoxycillin-clavulanic acid, enrofloxacin, cephalexin and gentamicin. The microorganism most frequently isolated from dogs with suppurative OE was Pseudomonas aeruginosa; in some cases Proteus, Streptococcus and Pasteurella were also isolated. The P aeruginosa isolates showed the highest sensitivity to gentamicin, polymyxin B and tobramycin.

Authors+Show Affiliations

Mycology Unit, University of Veterinary Science, Budapest, Hungary.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9065882

Citation

Kiss, G, et al. "New Combination for the Therapy of Canine Otitis Externa. I. Microbiology of Otitis Externa." The Journal of Small Animal Practice, vol. 38, no. 2, 1997, pp. 51-6.
Kiss G, Radványi S, Szigeti G. New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. J Small Anim Pract. 1997;38(2):51-6.
Kiss, G., Radványi, S., & Szigeti, G. (1997). New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. The Journal of Small Animal Practice, 38(2), 51-6.
Kiss G, Radványi S, Szigeti G. New Combination for the Therapy of Canine Otitis Externa. I. Microbiology of Otitis Externa. J Small Anim Pract. 1997;38(2):51-6. PubMed PMID: 9065882.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. AU - Kiss,G, AU - Radványi,S, AU - Szigeti,G, PY - 1997/2/1/pubmed PY - 1997/2/1/medline PY - 1997/2/1/entrez SP - 51 EP - 6 JF - The Journal of small animal practice JO - J Small Anim Pract VL - 38 IS - 2 N2 - In order to compound a new drug combination against canine otitis externa (OE), 515 dogs affected with OE were subjected to physical examination and microbiological analysis of their ear exudates. OE was erythematous-ceruminous in 83 per cent and suppurative in 17 per cent of the patient material. Erythematous-ceruminous inflammations were characterised by severe pruritus and accumulation of brownish, greasy cerumen in the auditory canal. The yeast Malassezia pachydermatis was isolated from the ears of 76 per cent of the dogs, often in combination with Staphylococcus intermedius bacteria. M pachydermatis showed the most sensitivity, in decreasing order of efficacy, to ketoconazole, econazole, clotrimazole, miconazole and nystatin. S intermedius isolates were most sensitive to amoxycillin-clavulanic acid, enrofloxacin, cephalexin and gentamicin. The microorganism most frequently isolated from dogs with suppurative OE was Pseudomonas aeruginosa; in some cases Proteus, Streptococcus and Pasteurella were also isolated. The P aeruginosa isolates showed the highest sensitivity to gentamicin, polymyxin B and tobramycin. SN - 0022-4510 UR - https://www.unboundmedicine.com/medline/citation/9065882/New_combination_for_the_therapy_of_canine_otitis_externa__I__Microbiology_of_otitis_externa_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0022-4510&date=1997&volume=38&issue=2&spage=51 DB - PRIME DP - Unbound Medicine ER -